|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
British Columbia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing British ColumbiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Arbutus Biopharma Corporation
| | | Phone: | (604) 419-3200 | Year Established: | 2005 | Ticker: | ABUS | Exchange: | NASDAQ | Main Contact: | Mark J. Murray PhD, President & CEO | | Other Contacts: | David C. Hastings, CFO Elizabeth Howard PhD, JD, Executive VP & General Counsel Michael J. Sofia PhD, CTO William T. Symonds PharmD, Chief Development Officer
| | Company Description | Arbutus Biopharma is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). | |
|
|
|
|
|